What is the cap color of topical carbonic anhydrase inhibitors (CAIs)?

Topical carbonic anhydrase inhibitors (CAIs), such as dorzolamide and brinzolamide, are commonly used medications for lowering intraocular pressure in conditions like glaucoma. The cap color associated with these specific agents is orange. This standardized color-coding helps healthcare professionals quickly identify the medication.

The use of color-coding in pharmaceuticals serves as an important visual cue that aids in preventing medication errors, particularly in a clinical setting where multiple medications may be present. Each category of ocular pharmacological agents typically has its designated cap color, making it easier to ensure that patients receive the correct medication. Therefore, recognizing that the cap color for topical CAIs is orange is essential for both proper dispensing and administration of these medications.